HLA-G and colorectal carcinoma: In addition, the studies in CRC and NSCLC patients analyzed the downstream pathways in cancer cells upon binding of HLA-G with the ILT4 receptor and showed increased phosphorylation of the ERK and AKT signaling pathways [79,81].